CD138-Negative Extra-oral Plasmablastic Lymphoma in an Immuno-competent Patient—Diagnostic Challenge: A Case Report and Review of Literature
Indian Journal of Medical and Paediatric Oncology · 20.05.2025
DOI: 10.1055/s-0045-1809302 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 20.05.2025. Verfasst von Shweta Katiyar und 7 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Plasmablastic lymphoma (PBL) is an aggressive lymphoid neoplasm, classified as a distinct entity in 2017 World Health Organization classification. These are generally associated with immunodeficiency states especially in human immunodeficiency virus (HIV)-infected individuals with oral cavity as the most common site. PBL cases have morphologic and immunophenotypic features lying within the spectrum of large B-cell lymphoma and multiple myeloma with tumor cells displaying plasmacytic immunohistochemical markers; CD38, CD138, and IRF4/MUM1. Diagnosis poses a challenge when CD138 immunohistochemistry (IHC) is negative and the tumor presents at extra-oral sites in an immunocompetent patient. We report an unusual case of CD138-negative PBL in an immunocompetent patient involving the gastrointestinal tract with extensive review of literature. The present case was a 51-year-old man who presented with abdominal fullness and pain. Imaging and endoscopy showed an extensive ulcero-proliferative lesion in the intestines involving the ascending colon to rectum and appendix. Small biopsy from the ascending colon was mistaken for an undifferentiated high-grade malignant neoplasm of uncertain lineage on limited IHC panel (negative CD45, Pan cytokeratin, Synaptophysin, CD20, CD3, but high Ki67). After an extensive workup on resected hemicolectomy specimen combined with various hematological parameters, the final diagnosis of CD138-negative PBL was made, with three notable features; CD138 negativity, extraoral site, and HIV negativity, leading to delay in diagnosis. Lesson learnt from this case was that PBLs may be CD138-negative that can be missed if not included in the differential diagnosis of tumors with uncertain line of differentiation.
Zitieren
APA
Katiyar, S., Verma, T., Dubey, A., Singhal, N., Gupta, A., Rangan, K., Verma, S. K., & Goel, M. M. (2025). CD138-Negative Extra-oral Plasmablastic Lymphoma in an Immuno-competent Patient—Diagnostic Challenge: A Case Report and Review of Literature. Indian Journal of Medical and Paediatric Oncology. https://doi.org/10.1055/s-0045-1809302
Vancouver
Katiyar S, Verma T, Dubey A, Singhal N, Gupta A, Rangan K, et al. CD138-Negative Extra-oral Plasmablastic Lymphoma in an Immuno-competent Patient—Diagnostic Challenge: A Case Report and Review of Literature. Indian Journal of Medical and Paediatric Oncology. 2025. doi:10.1055/s-0045-1809302
BibTeX
@article{Katiyar2025,
author = {Katiyar, Shweta and Verma, Tripti and Dubey, Ajita and Singhal, Niti and Gupta, Anshul and Rangan, Kasturi and Verma, Sandeep Kumar and Goel, Madhu Mati},
title = {CD138-Negative Extra-oral Plasmablastic Lymphoma in an Immuno-competent Patient—Diagnostic Challenge: A Case Report and Review of Literature},
journal = {Indian Journal of Medical and Paediatric Oncology},
year = {2025},
doi = {10.1055/s-0045-1809302}
}
EUVIMED